ReviewDrug design, development and therapy2026
Metabolomics-Driven Precision Prevention and Treatment of Heart Failure with Traditional Chinese Medicine: From Mechanistic Insights to Metabolic Network Regulation.
Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF), as the terminal clinical stage of diverse cardiovascular diseases, involves complex pathological mechanisms. Conventional Western medicines, which typically target individual molecules or pathways, may have limitations in comprehensively halting disease progression and can be associated with adverse effects. In contrast, Traditional Chinese Medicine (TCM) employs a holistic treatment strategy based on a "multi-component, multi-target, multi-pathway" principle (eg, Shenfu Injection, Linggui Zhugan Decoction), which may align more closely with the multifaceted pathophysiology of HF. However, the specific mechanisms underlying the therapeutic benefits of TCM have remained largely unclear, and most existing evidence is correlative rather than causal. Metabolomics, with its inherent strengths for holistic and dynamic analysis, offers a methodological framework for investigating the comprehensive effects and potential mechanisms of TCM interventions in HF. This review outlines the evolution of metabolomics technology platforms and their complementary applications in tackling the chemical complexity of TCM formulations, interpreting in vivo metabolic responses, and revealing spatial metabolic heterogeneity. The convergence of these technologies provides a foundation for a research paradigm centered on "problem orientation, technology matching, data integration, and hypothesis generation for mechanism elucidation". Furthermore, this paradigm has suggested potential synergistic mechanisms through which TCM regulates cardiac metabolism across multiple levels-from single active compounds and individual herbs to complex formulae. Collectively, these advances offer a useful reference for future research aimed at improving the precision and broader applicability of TCM in HF management, although most metabolomic findings remain associative and require validation through flux analysis, intervention studies, or clinical endpoint trials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.